From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs

RL McIntyre, EG Daniels, M Molenaars… - EMBO molecular …, 2019 - embopress.org
Reversing or slowing the aging process brings great promise to treat or prevent age‐related
disease, and targeting the hallmarks of aging is a strategy to achieve this. Epigenetics …

Immunoepigenetics combination therapies: an overview of the role of HDACs in cancer immunotherapy

D Banik, S Moufarrij, A Villagra - International journal of molecular …, 2019 - mdpi.com
Long-standing efforts to identify the multifaceted roles of histone deacetylase inhibitors
(HDACis) have positioned these agents as promising drug candidates in combatting cancer …

Drugs targeting epigenetic modifications and plausible therapeutic strategies against colorectal cancer

S Patnaik, Anupriya - Frontiers in Pharmacology, 2019 - frontiersin.org
Genetic variations along with epigenetic modifications of DNA are involved in colorectal
cancer (CRC) development and progression. CRC is the fourth leading cause of cancer …

Histone modifications: A review about the presence of this epigenetic phenomenon in carcinogenesis

ES Chrun, F Modolo, FI Daniel - Pathology-Research and Practice, 2017 - Elsevier
Among the epigenetic changes, histone acetylation has been recognized as a fundamental
process that strongly affects gene expression regulation. Disrupt of this phenomenon has …

Post-translational modifications in NETosis and NETs-mediated diseases

HJ Hamam, N Palaniyar - Biomolecules, 2019 - mdpi.com
Neutrophils undergo a unique form of cell death that generates neutrophil extracellular traps
(NETs) that may help to neutralize invading pathogens and restore homeostasis. However …

[HTML][HTML] Histone deacetylases (HDACs) guided novel therapies for T-cell lymphomas

Q Zhang, S Wang, J Chen, Z Yu - International journal of medical …, 2019 - ncbi.nlm.nih.gov
T-cell lymphomas are a heterogeneous group of cancers with different pathogenesis and
poor prognosis. Histone deacetylases (HDACs) are epigenetic modifiers that modulate …

[HTML][HTML] Anticancer clinical efficiency and stochastic mechanisms of belinostat

N El Omari, S Bakrim, A Khalid, M Albratty… - Biomedicine & …, 2023 - Elsevier
Cancer progression is strongly affected by epigenetic events in addition to genetic
modifications. One of the key elements in the epigenetic control of gene expression is …

The role of protein acetylation in carcinogenesis and targeted drug discovery

J Yang, C Song, X Zhan - Frontiers in Endocrinology, 2022 - frontiersin.org
Protein acetylation is a reversible post-translational modification, and is involved in many
biological processes in cells, such as transcriptional regulation, DNA damage repair, and …

Association of smoking, alcohol use, and betel quid chewing with epigenetic aberrations in cancers

TH Wang, SM Hsia, YH Shih, TM Shieh - International journal of …, 2017 - mdpi.com
Numerous environmental factors such as diet, alcohol use, stress, and environmental
chemicals are known to elicit epigenetic changes, leading to increased rates of cancers and …

Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?

MR Farani, M Sarlak, A Gholami, M Azaraian… - … -Research and Practice, 2023 - Elsevier
Epigenetics is the study of heritable changes in gene expression or function without altering
the DNA sequence. Important factors are part of epigenetic events, such as methylation …